{{Rsnum
|rsid=1562430
|Chromosome=8
|position=127375606
|Orientation=minus
|GMAF=0.3379
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=LOC101930033
|Gene_s=LOC101930033
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 41.1 | 47.3 | 11.6
| HCB | 62.8 | 33.6 | 3.6
| JPT | 71.7 | 25.7 | 2.7
| YRI | 25.2 | 50.3 | 24.5
| ASW | 31.6 | 47.4 | 21.1
| CHB | 62.8 | 33.6 | 3.6
| CHD | 69.4 | 28.7 | 1.9
| GIH | 61.4 | 30.7 | 7.9
| LWK | 40.9 | 48.2 | 10.9
| MEX | 56.9 | 39.7 | 3.4
| MKK | 42.9 | 47.4 | 9.6
| TSI | 34.3 | 50.0 | 15.7
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20453838
|Trait=Breast cancer
|Title=Genome-wide association study identifies five new breast cancer susceptibility loci
|RiskAllele=T
|Pval=6E-7
|OR=1.17
|ORtxt=[1.10-1.25]
|OA=1
}}

{{PMID Auto GWAS
|PMID=21263130
|Trait=None
|Title=Novel Breast Cancer Susceptibility Locus at 9q31.2: Results of a Genome-Wide Association Study
|RiskAllele=A
|Pval=3E-11
|OR=1.1600
|ORtxt=[1.11-1.22]
}}

{{PMID Auto
|PMID=21445572
|Title=Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies
}}

{{PMID Auto
|PMID=22275265
|Title=Common genetic variants in the 8q24 region and risk of papillary thyroid cancer
|OA=1
}}

{{PMID Auto
|PMID=22452962
|Title=A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study
|OA=1
}}

{{PMID|19330030|OA=1
}} A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}